Loosen, S. H., Gorgulho, J., Jördens, M. S., Schulze-Hagen, M., Beier, F., Vucur, M., . . . Luedde, T. (2021). Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy. Front Oncol.
Styl ChicagoLoosen, Sven H., et al. "Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy." Front Oncol 2021.
Citace podle MLALoosen, Sven H., et al. "Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy." Front Oncol 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..